Literature DB >> 9453652

Role of tumor necrosis factor alpha in the host response of mice to bacteremia caused by pneumolysin-deficient Streptococcus pneumoniae.

K A Benton1, J L VanCott, D E Briles.   

Abstract

Pneumolysin-deficient mutant strains of Streptococcus pneumoniae are known to cause less-severe sepsis than wild-type pneumococcal strains that produce pneumolysin. This difference is associated with greater host resistance in mice infected with the pneumolysin-deficient strains. These studies show that the host resistance developed during the first 1 to 2 days after infection with a pneumolysin-deficient mutant strain is dependent on tumor necrosis factor alpha but is apparently independent of interleukin 1beta (IL-1beta) or IL-6. Survival beyond 5 days appeared to depend on the ability of the mice to produce IL-1beta.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9453652      PMCID: PMC107980     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  The hemolytic and complement-activating properties of pneumolysin do not contribute individually to virulence in a pneumococcal bacteremia model.

Authors:  K A Benton; J C Paton; D E Briles
Journal:  Microb Pathog       Date:  1997-10       Impact factor: 3.738

2.  STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES : INDUCTION OF TRANSFORMATION BY A DESOXYRIBONUCLEIC ACID FRACTION ISOLATED FROM PNEUMOCOCCUS TYPE III.

Authors:  O T Avery; C M Macleod; M McCarty
Journal:  J Exp Med       Date:  1944-02-01       Impact factor: 14.307

3.  Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae.

Authors:  D E Briles; M J Crain; B M Gray; C Forman; J Yother
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

4.  Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae.

Authors:  A M Berry; J Yother; D E Briles; D Hansman; J C Paton
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

5.  Effect of defined point mutations in the pneumolysin gene on the virulence of Streptococcus pneumoniae.

Authors:  A M Berry; J E Alexander; T J Mitchell; P W Andrew; D Hansman; J C Paton
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

6.  Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment.

Authors:  W B van den Berg; L A Joosten; M Helsen; F A van de Loo
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

7.  Neutralization of interleukin-1 beta activity in vivo with a monoclonal antibody alleviates collagen-induced arthritis in DBA/1 mice and prevents the associated acute-phase response.

Authors:  T Geiger; H Towbin; A Cosenti-Vargas; O Zingel; J Arnold; C Rordorf; M Glatt; K Vosbeck
Journal:  Clin Exp Rheumatol       Date:  1993 Sep-Oct       Impact factor: 4.473

8.  Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra.

Authors:  L A Joosten; M M Helsen; F A van de Loo; W B van den Berg
Journal:  Arthritis Rheum       Date:  1996-05

9.  Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 beta by human mononuclear phagocytes.

Authors:  S Houldsworth; P W Andrew; T J Mitchell
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

10.  The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis.

Authors:  K Saukkonen; S Sande; C Cioffe; S Wolpe; B Sherry; A Cerami; E Tuomanen
Journal:  J Exp Med       Date:  1990-02-01       Impact factor: 14.307

View more
  11 in total

1.  Acquired, but not innate, immune responses to Streptococcus pneumoniae are compromised by neutralization of CD40L.

Authors:  Y i Hwang; M H Nahm; D E Briles; D Thomas; J M Purkerson
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Differential PsaA-, PspA-, PspC-, and PdB-specific immune responses in a mouse model of pneumococcal carriage.

Authors:  Ravichandran Palaniappan; Shailesh Singh; Udai P Singh; Senthil Kumar K Sakthivel; Edwin W Ades; David E Briles; Susan K Hollingshead; James C Paton; Jacquelyn S Sampson; James W Lillard
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 3.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

Review 4.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

Review 5.  The role of pneumolysin in pneumococcal pneumonia and meningitis.

Authors:  R A Hirst; A Kadioglu; C O'callaghan; P W Andrew
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

6.  Differential activation of the immune system by virulent Streptococcus pneumoniae strains determines recovery or death of the host.

Authors:  Y Mizrachi-Nebenzahl; S Lifshitz; R Teitelbaum; S Novick; A Levi; D Benharroch; E Ling; R Dagan
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

Review 7.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

8.  Pneumococcal virulence gene expression and host cytokine profiles during pathogenesis of invasive disease.

Authors:  Layla K Mahdi; Abiodun D Ogunniyi; Kim S LeMessurier; James C Paton
Journal:  Infect Immun       Date:  2007-11-26       Impact factor: 3.441

9.  Pneumolysin-dependent and -independent gene expression identified by cDNA microarray analysis of THP-1 human mononuclear cells stimulated by Streptococcus pneumoniae.

Authors:  P David Rogers; Justin Thornton; Katherine S Barker; D Olga McDaniel; Gordon S Sacks; Edwin Swiatlo; Larry S McDaniel
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

10.  Tumor necrosis factor alpha receptor I is important for survival from Streptococcus pneumoniae infections.

Authors:  D P O'Brien; D E Briles; A J Szalai; A H Tu; I Sanz; M H Nahm
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.